# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-02-19)

**Core value:** Validated architectural decisions backed by evidence, not gut feel
**Current focus:** Phase 2 — Eval Framework

## Current Position

Phase: 2 of 6 (Eval Framework)
Plan: 1 of 3 in current phase (COMPLETE)
Status: Plan 02-01 complete — continuing to 02-02
Last activity: 2026-02-19 — Eval data layer (scenarios + variants) built

Progress: [██░░░░░░░░] 20%

## Performance Metrics

**Velocity:**
- Total plans completed: 2
- Average duration: 4min
- Total execution time: 7min

**By Phase:**

| Phase | Plans | Total | Avg/Plan |
|-------|-------|-------|----------|
| 1. Codebase Alignment Audit | 1 | 5min | 5min |
| 2. Eval Framework | 1 | 2min | 2min |

**Recent Trend:**
- Last 5 plans: 01-01 (5min), 02-01 (2min)
- Trend: accelerating

*Updated after each plan completion*

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table.
Recent decisions affecting current work:

- Roadmap: 6 phases derived from 12 requirements. Audit first, then eval infra, then experiment, then ADR.
- Roadmap: Each phase has an approval gate — no automatic progression.
- Audit: Memory (Mem0) is highest-impact misalignment (score 8/10) -- needs architectural replacement in future milestone.
- Audit: Tasks subsystem confirmed as correct first experiment target for apps-vs-tools hypothesis.
- Audit: 3 subsystems (Graph Core, Context Management, Sandbox) have zero misalignments -- no action needed.
- Eval: YAML scenarios use typed dataclasses (Scenario, ScenarioAssertion) not raw dicts
- Eval: Variant registry uses decorator pattern -- new variant = decorate a function in a new file
- Eval: Baseline variant includes 4 tools (schedule_task, list_tasks, update_task, run_code) matching production

### Pending Todos

None yet.

### Blockers/Concerns

None yet.

## Session Continuity

Last session: 2026-02-19
Stopped at: Completed 02-01-PLAN.md (eval data layer)
Resume file: .planning/phases/02-eval-framework/02-01-SUMMARY.md
